In this Issue:
Risk prediction equations to estimate blindness and amputation risks
Marijuana use and prediabetes/ diabetes risk
LDL cholesterol levels and incident diabetes risk
Empagliflozin’s effects on BP, arterial stiffness and vascular resistance in type 2 diabetes
CV disease, mortality and case fatality with diabetes/metabolic syndrome
Performance/usability of a factorycalibrated flash glucose monitoring system
Challenging the role of metformin as first-line for type 2 diabetes
Who benefits from early specialist diabetes care?
Pioglitazone after ischaemic stroke/ TIA
Excise tax reduces SSB purchases in Mexico
Please login below to download this issue (PDF)